Attovia Therapeutics Secures $289 Million in Upsized IPO, Signifying Robust Biotech Market Recovery
Attovia Therapeutics, a burgeoning biotechnology firm focused on innovative antibody-drug technologies for skin disorders and...
Knowledge and News for the Global Fight Against Cancer.
Attovia Therapeutics, a burgeoning biotechnology firm focused on innovative antibody-drug technologies for skin disorders and...
The Cancer Research Institute (CRI) has proudly unveiled its 2026 class of Lloyd J. Old...
Expedition Therapeutics, a rapidly emerging biotechnology company focused on bringing innovative therapies to market, announced...
The biopharmaceutical landscape has recently been marked by a series of significant developments, including a...
New York, NY – August 4, 2026 – Pfizer Inc. today announced a significant expansion...
Vertex Pharmaceuticals, a titan in the biotechnology sector, recently reported stellar financial results for the...
In a significant move to bolster the production of critical GLP-1 injectable medications, contract manufacturer...
In a significant move poised to reshape the specialty pharmaceutical landscape, Supernus Pharmaceuticals has announced...
BioNTech, the German biotechnology firm that rose to global prominence for its pioneering COVID-19 vaccine,...
Rumors of a potential megamerger between pharmaceutical giants AstraZeneca and Bristol Myers Squibb have sent...